Deschloroclotizolam
Appearance
Source: Wikipedia, the free encyclopedia.
Designer drug
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
JSmol) | |
| |
|
Deschloroclotizolam is a thienotriazolodiazepine derivative which has been sold as a designer drug, first being identified in Sweden in 2021.[1]
See also
References
- ISBN 978-92-9497-737-3.
GABAA |
| ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GABAB | |||||||||||||||||||||||||
Antihistamines | |||||||||||||||||||||||||
Antidepressants |
| ||||||||||||||||||||||||
Antipsychotics |
Antidepressants | |
---|---|
Antipsychotics | |
Others |
- Agomelatine
- Melatonin
- Ramelteon
- Tasimelteon
- Cannabidiol
- Chlorophenylalkyldiols
- Diethylpropanediol
- Evoxine
- Fenadiazole
- Guaifenesin-related muscle relaxants
- Chlorphenesin
- Mephenesin
- Mephenoxalone
- Metaxalone
- Methocarbamol
- Midaflur
- Opioids (e.g., morphine)
- Passion flower
- Scopolamine
- Trazodone
- UMB68
- Valnoctamide
This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |